drugs
publication date
Strategy
States Move Ahead With Canada Drug Importation While Awaiting Signal From BidenThe Pharmaceutical Research and Manufacturers of America, an industry trade group, filed suit in federal court in Washington, D.C., to...
Revenue Cycle
AHA: CMS Should Reconsider Most Favored Nation ModelThe rule places financial burden on provider organizations and forces them to divert resources to purchase drugs necessary for patient...
Strategy
San Francisco Wrestles With Drug Approach as Death and Chaos Engulf TenderloinSan Francisco is on track to lose an average of nearly two people a day to drugs in 2020, compared...
Innovation
LifeBridge Uses COVID-19 Vaccine App to Manage Complex Scheduling and Communications ProcessesThe GetWellNetwork tool offers a method to relieve overburdened workers and boost compliance rates among vaccine recipients.
Revenue Cycle
CMS Clarifies Use of New Condition Codes 90 and 91The National Uniform Billing Committee (NUBC) recently created the condition codes for use on healthcare claims, effective February 1, 2021.
Finance
Pharmaceutical Payments to Physicians Associated with Increased PrescribingThe research indicated that the findings were "consistent across all studies," adding that the pharmaceutical-physician association caused doctors to prescribe...
Strategy
Surprise Federal Drug Rule Directs Insurers to Reveal What They Pay for Prescription DrugsThe drug price provisions, which would not begin until 2022, were a surprise because they were not included in the...
Strategy
Patients Struggle to Find Prescription Opioids After NY Tax Drives Out SuppliersPain patients in New York have lost access to vital medicine since July 2019, when the state implemented an excise...
Clinical Care
Fewer Physicians Accepting Industry Payments, But Payment Values Stay SteadyA new study highlights the importance of tracking physician conflicts of interest.
Finance
17 States Have Implemented or Explored Prescription Drug Affordability Review Boards A new report from Manatt Health reviews the "current legislative landscape pertaining to" drug affordability review boards.
Strategy
Drug Lobby Rips Trump's 'Most Favored Nation' Mandate on Medicare Drug PricesPhRMA says the White House has "doubled down on a reckless attack on the very companies working around the clock...
Clinical Care
Many Hospitals Still Don't Have Drug Diversion ProgramsCDC information shows the increase in the frequency of disease outbreaks stemming from drug diversion.